Navigation Links
Modigene to Present at the BIO-Europe Spring(R) 2009 Conference

NES-ZIONA, Israel, March 10 /PRNewswire/ -- Modigene Inc. (OTC Bulletin Board: MODG), a biopharmaceutical company developing a long-acting human growth hormone and other proprietary longer-acting versions of already approved therapeutic proteins, today announced that CEO Avri Havron will present at the upcoming BIO-Europe Spring(R) 2009 Conference at 10:00 AM (local time) on March 17, 2009. The conference will be held at the Milano Convention Center in Milan, Italy from March 16-18, 2009.

For more information about the BIO-Europe Spring(R) 2009 Conference, visit


Modigene Inc. is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta and erythropoietin, which are in late preclinical development, as well as GLP-1. For more information on Modigene, visit

    MODIGENE CONTACT:                         MEDIA CONTACT:
    Shai Novik, President                     Barbara Lindheim
    Modigene Inc.                             GendeLLindheim BioCom Partners
    Tel: +1 866 644-7811                      +1 212 918-4650

SOURCE Modigene Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Modigene Sets Record Date for Annual Meeting of Shareholders
2. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
3. Modigene to Present at the UBS Global Life Sciences Conference
4. Modigene to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
6. Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. Modigene to Present at the Roth 2007 New York Investor Conference
8. NxStage to Present at the Cowen and Company 29th Annual Healthcare Conference
9. WaferGen to Present Data on SmartChip(TM) Real-Time PCR System at Cambridge Healthtech Institutes Quantitative PCR Conference
10. Kendle to Present at Upcoming Barclays Capital and Raymond James Conferences
11. Cynvec LLC(SM) to Present at the Cowen and Company 29th Annual Health Care Conference
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... 23, 2016 Andrew ... Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):